Numans Health Food Holdings Company Limited (HKG:2530)
Hong Kong · Delayed Price · Currency is HKD 0.7350
0.00 (0.00%)
Aug 21, 2026, 10:28 AM HKT
HKG:2530 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 735 | 620 | - | - | - | - | |
Market Cap Growth | 14.84% | - | - | - | - | - |
Enterprise Value | 292 | 162 | - | - | - | - |
Last Close Price | 0.73 | 0.60 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 119.22 | 101.24 | - | - | - | - |
PS Ratio | 3.49 | 2.94 | - | - | - | - |
PB Ratio | 1.33 | 1.13 | - | - | - | - |
P/TBV Ratio | 1.35 | 1.14 | - | - | - | - |
P/FCF Ratio | 15.07 | 12.71 | - | - | - | - |
P/OCF Ratio | 15.05 | 12.70 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.39 | 0.77 | - | - | - | - |
EV/EBITDA Ratio | 12.29 | 8.32 | - | - | - | - |
EV/EBIT Ratio | 15.69 | 8.71 | - | - | - | - |
EV/FCF Ratio | 5.99 | 3.33 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 |
Debt / EBITDA Ratio | 0.18 | 0.18 | 0.04 | 0.03 | 0.07 | 0.01 |
Debt / FCF Ratio | 0.09 | 0.09 | 0.05 | 0.04 | 0.17 | 0.01 |
Net Debt / Equity Ratio | -0.80 | -0.80 | -0.61 | -0.63 | -0.75 | -0.75 |
Net Debt / EBITDA Ratio | -22.67 | -22.67 | -2.09 | -1.25 | -1.78 | -0.91 |
Net Debt / FCF Ratio | -9.07 | -9.07 | -2.81 | -1.71 | -4.30 | -1.63 |
Asset Turnover | 0.41 | 0.41 | 0.63 | 0.98 | 1.06 | - |
Inventory Turnover | 1.64 | 1.64 | 1.03 | 1.69 | 2.51 | - |
Quick Ratio | 25.87 | 25.87 | 8.04 | 5.89 | 1.73 | 2.48 |
Current Ratio | 28.93 | 28.93 | 10.63 | 7.77 | 2.40 | 3.25 |
Return on Equity (ROE) | 1.26% | 1.26% | 19.04% | 48.48% | 38.92% | - |
Return on Assets (ROA) | 2.25% | 2.25% | 15.49% | 29.26% | 18.55% | - |
Return on Invested Capital (ROIC) | 4.10% | 3.29% | 55.36% | 155.62% | 161.82% | 250.65% |
Return on Capital Employed (ROCE) | 3.40% | 3.40% | 29.00% | 49.50% | 40.80% | 81.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.83% | 0.99% | - | - | - | - |
FCF Yield | 6.64% | 7.87% | - | - | - | - |
Dividend Yield | 3.93% | 4.63% | - | - | - | - |
Payout Ratio | 908.60% | 908.60% | 146.86% | 50.21% | 5.70% | 22.57% |
Buyback Yield / Dilution | -32.42% | -32.42% | - | - | - | - |
Total Shareholder Return | -28.49% | -27.79% | - | - | - | - |